Natalie Dean is an Assistant Professor in the Department of Biostatistics and Bioinformatics at Emory’s Rollins School of Public Health. She received her PhD in Biostatistics from Harvard University. She previously worked as a World Health Organization consultant and as faculty at University of Florida. Her primary research area is in methods for infectious disease epidemiology and vaccine study design, and she co-directs the Emory Alliance for Vaccine Epidemiology.
She/her/hers
Brazil
United States
Thailand
Mexico
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Ruoran Li, Natalie Dean
2024 – 2027 Continue Reading Summer Institute in Statistics and Modeling in Infectious Diseases
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Ira Longini, Natalie Dean
2018 – 2025 Continue Reading Design and Analysis of Vaccine Trials for Emerging Infectious Disease Threats
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Ira Longini, Natalie Dean, Yang Yang, M Halloran
2015 – 2022 Continue Reading Methods for Evaluating Vaccine Efficacy
Dean NE, Rivers CM. (2026). Making infectious disease data local and as accessible as the weather forecast. Nature medicine
Rogawski McQuade E, Nabi R, Codi A, Dean N, Lipsitch M, Benkeser D. (2026). Vaccine Efficacy Against Naturally Asymptomatic Infections: A Novel Estimand for Quantifying Vaccine Effects. Epidemiology (Cambridge, Mass.)
Brouwer AF, Eisenberg MC, Dean NE, Hochheiser H, Huang P, Coyle JR, Rennert L. (2026). Infectious disease modeling for public health practice: projections, scenarios, and uncertainty in three phases of outbreak response. American journal of epidemiology
Barrera-Fuentes GA, Antonioli C, Pavia-Ruz N, Che-Mendoza A, Earnest JT, Kirstein OD, Eb-Cordova AB, Ciau-Carillo KJ, Jabbarzadeh S, Granja-Perez P, Villanueva-Jorge S, Puerta-Guardo H, Collins MH, Ayora-Talavera G, Halloran ME, Longini IM, Dean N, Waller LA, Crisp A, Manrique-Saide P, Vazquez-Prokopec GM, Gomez-Dantes H. (2026). Integrated Surveillance Strategies and Clinical Characteristics of Arboviral Diseases in a Pediatric Cohort in Merida, Mexico, 2021-2023. The American journal of tropical medicine and hygiene, 115(1)
Jayawardena I, Dean NE, Witrick B, Litwin AH, Rennert L. (2026). 2024-2025 COVID-19 mRNA Vaccine Effectiveness against Severe Disease. The Journal of infectious diseases
Dean N. (2026). Why the Test-Negative Design Is Used for Routine Vaccine Monitoring. JAMA network open, 9(6)
Harton PE, Chamberlain AT, Moore A, Fletcher G, Nelson KN, Dean N, Lopman B, Rogawski McQuade ET. (2025). Estimating COVID-19 vaccine effectiveness among children and adolescents using data from a school-based weekly COVID-19 testing program. Vaccine, (61)
Moore SM, Rapheal E, Mendoza Guerrero S, Dean NE, Stoddard ST. (2025). Estimation of Lassa fever incidence rates in West Africa: Development of a modeling framework to inform vaccine trial design. PLoS neglected tropical diseases, 19(7)
Crisp AM, Halloran ME, Hitchings MDT, Longini IM, Dean NE. (2025). Analysis methods for covariate-constrained cluster randomized trials with time-to-event outcomes. BMC medical research methodology, 25(1)
Ranzani OT, Lazar Neto F, Mareto LK, Brumatti TS, de Oliveira RD, da Silva PV, Dos Santos ER, D' Agostini TL, De Paula RAC, Dean NE, Ko AI, Cummings DAT, Andrews JR, Hitchings MDT, Croda J. (2025). Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in São Paulo, Brazil: a test-negative, case-control study. The Lancet. Infectious diseases
Billings WZ, Ge Y, Skarlupka AL, Miller SL, Hemme H, John M, Dean NE, Cobey S, Cowling BJ, Shen Y, Ross TM, Handel A. (2025). Different antigenic distance metrics generate similar predictions of influenza vaccine response breadth despite moderate correlation. PLoS computational biology, 21(11)
Ricotta EE, Bustos Carrillo FA, Angelli-Nichols S, Barugahare J, Benton A, Carlson CJ, Chang-Rabley E, Dean NE, Duda SN, Federer L, Fill MA, LeRoy EC, Linton NM, Lipsitch M, Mathur MB, Phelan AL, Rid A, Rosen JB, Sauer L, Sullivan SG, Zendt M, Evans N. (2025). Observational research in epidemic settings: a roadmap to reform. BMJ global health, 10(2)
Dean NE, Crisp AM, Che-Mendoza A, Kirstein OD, Barrera-Fuentes GA, Earnest JT, Puerta-Guardo HN, Collins MH, Pavia-Ruz N, Ayora-Talavera G, González-Olvera G, Medina-Barreiro A, Bibiano-Marín W, Jabbarzadeh S, Halloran ME, Longini IM Jr., Lenhart A, Waller LA, Correa-Morales F, Palacio-Vargas J, Gomez-Dantes H, Manrique-Saide P, Vazquez-Prokopec GM. (2025). Randomized Trial of Targeted Indoor Spraying to Prevent Aedes-Borne Diseases. The New England journal of medicine, 393(14)
Meyer AD, Guerrero SM, Dean NE, Anderson KB, Stoddard ST, Perkins TA. (2025). Predictability of infectious disease outbreak severity: Chikungunya as a case study. Science advances, 11(40)
Amin AB, Hitchings MDT, Ranzani OT, Andrews JR, Cummings DAT, Ko AI, Croda J, Dean NE. (2024). Severity-dependent test-seeking behaviors and test-negative designs: impact on estimated vaccine effectiveness and utility of analytic and design choices. American journal of epidemiology
Dean NE, Halloran ME, Zarnitsyna VI. (2024). Poor vaccine responders mask the true trend in vaccine effectiveness against progression to severe disease. Vaccine, 43(Pt 2)
Earnest JT, Kirstein OD, Mendoza AC, Barrera-Fuentes GA, Puerta-Guardo H, Parra-Cardeña M, Yam-Trujillo K, Collins MH, Pavia-Ruz N, Ayora-Talavera G, Gonzalez-Olvera G, Medina-Barreiro A, Bibiano-Marin W, Lenhart A, Halloran ME, Longini I, Dean N, Waller LA, Crisp AM, Correa-Morales F, Palacio-Vargas J, Granja-Perez P, Villanueva S, Delfın-Gonzalez H, Gomez-Dantes H, Manrique-Saide P, Vazquez-Prokopec GM. (2024). The TIRS trial: Enrollment procedures and baseline characterization of a pediatric cohort to quantify the epidemiologic impact of targeted indoor residual spraying on Aedes-borne viruses in Merida, Mexico. PloS one, 19(9)
Huo Y, Yang Y, Halloran ME, Longini IM Jr., Dean NE. (2024). Hypothesis testing and sample size considerations for the test-negative design. BMC medical research methodology, 24(1)
Wang R, Cen M, Huang Y, Qian G, Dean NE, Ellenberg SS, Fleming TR, Lu W, Longini IM. (2024). Methods for the estimation of direct and indirect vaccination effects by combining data from individual- and cluster-randomized trials. Statistics in medicine
Lazar Neto F, Hitchings MDT, Amin AB, de França GVA, Lind ML, Scaramuzzini Torres MS, Tsuha DH, de Oliveira RD, Cummings DAT, Dean NE, Andrews JR, Ko AI, Croda J, Ranzani OT. (2024). Effectiveness of the fourth dose of COVID-19 vaccines against severe COVID-19 among adults 40 years or older in Brazil: a population-based cohort study. Lancet regional health. Americas, (34)
Dean N, Amin AB. (2024). Test-Negative Study Designs for Evaluating Vaccine Effectiveness. JAMA
Huo Y, Yang Y, Halloran ME, Longini IM Jr., Dean NE. (2023). Hypothesis testing and sample size considerations for the test-negative design. Research square
Rich SN, Richards V, Mavian C, Rife Magalis B, Grubaugh N, Rasmussen SA, Dellicour S, Vrancken B, Carrington C, Fisk-Hoffman R, Danso-Odei D, Chacreton D, Shapiro J, Seraphin MN, Hepp C, Black A, Dennis A, Trovão NS, Vandamme AM, Rasmussen A, Lauzardo M, Dean N, Salemi M, Prosperi M. (2023). Application of Phylodynamic Tools to Inform the Public Health Response to COVID-19: Qualitative Analysis of Expert Opinions. JMIR formative research, (7)
Madewell ZJ, Yang Y, Longini IM Jr., Halloran ME, Vespignani A, Dean NE. (2023). Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants. BMC infectious diseases, 23(1)
Meyer AD, Guerrero SM, Dean NE, Anderson KB, Stoddard ST, Perkins TA. (2023). Model-based estimates of chikungunya epidemiological parameters and outbreak risk from varied data types. Epidemics, (45)
Crisp AM, Halloran ME, Longini IM, Vazquez-Prokopec G, Dean NE. (2023). Covariate-constrained randomization with cluster selection and substitution. Clinical trials (London, England), 20(3)
Gozzi N, Chinazzi M, Dean NE, Longini IM Jr., Halloran ME, Perra N, Vespignani A. (2023). Estimating the impact of COVID-19 vaccine inequities: a modeling study. Nature communications, 14(1)
Madewell ZJ, Wang LP, Dean NE, Zhang HY, Wang YF, Zhang XA, Liu W, Yang WZ, Longini IM, Gao GF, Li ZJ, Fang LQ, Yang Y, . (2023). Interactions among acute respiratory viruses in Beijing, Chongqing, Guangzhou, and Shanghai, China, 2009-2019. Influenza and other respiratory viruses, 17(11)
Hitchings MDT, Lewnard JA, Dean NE, Ko AI, Ranzani OT, Andrews JR, Cummings DAT. (2022). Use of recently vaccinated individuals to detect bias in test-negative case-control studies of COVID-19 vaccine effectiveness. Epidemiology (Cambridge, Mass.)
Madewell ZJ, Yang Y, Longini IM Jr., Halloran ME, Dean NE. (2022). Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis. JAMA network open, 5(4)
Cerqueira-Silva T, Andrews JR, Boaventura VS, Ranzani OT, de Araújo Oliveira V, Paixão ES, Júnior JB, Machado TM, Hitchings MDT, Dorion M, Lind ML, Penna GO, Cummings DAT, Dean NE, Werneck GL, Pearce N, Barreto ML, Ko AI, Croda J, Barral-Netto M. (2022). Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study. The Lancet. Infectious diseases
Lind ML, Robertson AJ, Silva J, Warner F, Coppi AC, Price N, Duckwall C, Sosensky P, Di Giuseppe EC, Borg R, Fofana MO, Ranzani OT, Dean NE, Andrews JR, Croda J, Iwasaki A, Cummings DAT, Ko AI, Hitchings MDT, Schulz WL. (2022). Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case-control analysis. PLoS medicine, 19(12)
Dean NE, Longini IM. (2022). The ring vaccination trial design for the estimation of vaccine efficacy and effectiveness during infectious disease outbreaks. Clinical trials (London, England)
Gozzi N, Chinazzi M, Dean NE, Longini IM Jr., Halloran ME, Perra N, Vespignani A. (2022). Estimating the impact of COVID-19 vaccine allocation inequities: a modeling study. medRxiv : the preprint server for health sciences
Aleta A, Martín-Corral D, Bakker MA, Pastore Y Piontti A, Ajelli M, Litvinova M, Chinazzi M, Dean NE, Halloran ME, Longini IM Jr., Pentland A, Vespignani A, Moreno Y, Moro E. (2022). Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas. Proceedings of the National Academy of Sciences of the United States of America, 119(26)
Hitchings MDT, Ranzani OT, Lind ML, Dorion M, D'Agostini TL, de Paula RC, de Paula OFP, de Moura Villela EF, Scaramuzzini Torres MS, de Oliveira SB, Schulz W, Almiron M, Said R, de Oliveira RD, Vieira da Silva P, de Araújo WN, Gorinchteyn JC, Dean NE, Andrews JR, Cummings DAT, Ko AI, Croda J. (2022). Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study. BMJ (Clinical research ed.), (377)
Koelle K, Martin MA, Antia R, Lopman B, Dean NE. (2022). The changing epidemiology of SARS-CoV-2. Science (New York, N.Y.), 375(6585)
Dean NE, Halloran ME. (2022). Protecting the herd with vaccination. Science (New York, N.Y.), 375(6585)
Ranzani OT, Hitchings MDT, de Melo RL, de França GVA, Fernandes CFR, Lind ML, Torres MSS, Tsuha DH, David LCS, Said RFC, Almiron M, de Oliveira RD, Cummings DAT, Dean NE, Andrews JR, Ko AI, Croda J. (2022). Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil. Nature communications, 13(1)
Dat VQ, Anh NTL, Van Nghia K, Linh NT, Thu HHK, Tam TTM, Ton T, Anh LQ, Phuc ND, Huong PTT, Nhan DT, Hai NH, Bertagnolio S, Crisp AM, Inzaule S, Dean NE, Jordan MR, Nguyen VTT. (2022). The prevalence of pre-treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey, 2017-2018. Journal of the International AIDS Society, 25(2)
Davis JT, Chinazzi M, Perra N, Mu K, Piontti APY, Ajelli M, Dean NE, Gioannini C, Litvinova M, Merler S, Rossi L, Sun K, Xiong X, Halloran ME, Longini IM Jr., Viboud C, Vespignani A. (2021). Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States. medRxiv : the preprint server for health sciences
Davis JT, Chinazzi M, Perra N, Mu K, Pastore Y Piontti A, Ajelli M, Dean NE, Gioannini C, Litvinova M, Merler S, Rossi L, Sun K, Xiong X, Longini IM Jr., Halloran ME, Viboud C, Vespignani A. (2021). Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave. Nature
Hitchings MDT, Ranzani OT, Lind ML, Dorion M, D'Agostini TL, de Paula RC, de Paula OFP, de Moura Villela EF, Torres MSS, de Oliveira SB, Schulz W, Almiron M, Said R, de Oliveira RD, da Silva PV, de Araújo WN, Gorinchteyn JC, Dean NE, Andrews JR, Cummings DAT, Ko AI, Croda J. (2021). Change in COVID-19 risk over time following vaccination with CoronaVac: A testnegative case-control study. medRxiv : the preprint server for health sciences
Dean N. (2021). Hospital admissions due to COVID-19 in Scotland after one dose of vaccine. Lancet
Giovanetti M, Cella E, Benedetti F, Rife Magalis B, Fonseca V, Fabris S, Campisi G, Ciccozzi A, Angeletti S, Borsetti A, Tambone V, Sagnelli C, Pascarella S, Riva A, Ceccarelli G, Marcello A, Azarian T, Wilkinson E, de Oliveira T, Alcantara LCJ, Cauda R, Caruso A, Dean NE, Browne C, Lourenço J, Salemi M, Zella D, Ciccozzi M. (2021). SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy. Communications biology, 4(1)
Li F, Li YY, Liu MJ, Fang LQ, Dean NE, Wong GWK, Yang XB, Longini I, Halloran ME, Wang HJ, Liu PL, Pang YH, Yan YQ, Liu S, Xia W, Lu XX, Liu Q, Yang Y, Xu SQ. (2021). Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study. The Lancet. Infectious diseases
Hitchings MDT, Dean NE, Garcia-Carreras B, Hladish TJ, Huang AT, Yang B, Cummings DAT. (2021). The Usefulness Of SARS-CoV-2 Test-Positive Proportion As A Surveillance Tool. American journal of epidemiology
Dean N. (2021). Statistical successes and failures during the COVID-19 pandemic: Comments on Ellenberg and Morris. Statistics in medicine, 40(11)
Madewell ZJ, Yang Y, Longini IM Jr., Halloran ME, Dean NE. (2021). Factors Associated With Household Transmission of SARS-CoV-2: An Updated Systematic Review and Meta-analysis. JAMA network open, 4(8)
Madewell ZJ, Yang Y, Longini IM Jr., Halloran ME, Dean NE. (2020). Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate. medRxiv : the preprint server for health sciences
Madewell ZJ, Yang Y, Longini IM Jr., Halloran ME, Dean NE. (2020). Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis. JAMA network open, 3(12)
Lipsitch M, Dean NE. (2020). Understanding COVID-19 vaccine efficacy. Science (New York, N.Y.)
Aleta A, Martin-Corral D, Pastore Y Piontti A, Ajelli M, Litvinova M, Chinazzi M, Dean NE, Halloran ME, Longini IM, Merler S, Pentland A, Vespignani A, Moro E, Moreno Y. (2020). Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic. medRxiv : the preprint server for health sciences
Jing QL, Liu MJ, Zhang ZB, Fang LQ, Yuan J, Zhang AR, Dean NE, Luo L, Ma MM, Longini I, Kenah E, Lu Y, Ma Y, Jalali N, Yang ZC, Yang Y. (2020). Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. The Lancet. Infectious diseases
Dean NE, Halloran ME, Longini IM Jr.. (2020). Temporal Confounding in the Test Negative Design. American journal of epidemiology
Kimmel SE, Califf RM, Dean NE, Goodman SN, Ogburn EL. (2020). COVID-19 Clinical Trials: A Teachable Moment for Improving Our Research Infrastructure and Relevance. Annals of internal medicine
Cardel MI, Dean N, Montoya-Williams D. (2020). Preventing a Secondary Epidemic of Lost Early Career Scientists: Effects of COVID-19 Pandemic on Women with Children. Annals of the American Thoracic Society
Jing QL, Liu MJ, Yuan J, Zhang ZB, Zhang AR, Dean NE, Luo L, Ma M, Longini I, Kenah E, Lu Y, Ma Y, Jalali N, Fang LQ, Yang ZC, Yang Y. (2020). Household Secondary Attack Rate of COVID-19 and Associated Determinants. medRxiv : the preprint server for health sciences
Dean NE, Pastore Y Piontti A, Madewell ZJ, Cummings DAT, Hitchings MDT, Joshi K, Kahn R, Vespignani A, Halloran ME, Longini IM Jr.. (2020). Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials. Vaccine
Ogburn EL, Bierer BE, Brookmeyer R, Choirat C, Dean NE, De Gruttola V, Ellenberg SS, Halloran ME, Hanley DF Jr., Lee JK, Wang R, Scharfstein DO. (2020). Aggregating data from COVID-19 trials. Science (New York, N.Y.), 368(6496)
Jordan MR, Hamunime N, Bikinesi L, Sawadogo S, Agolory S, Shiningavamwe AN, Negussie T, Fisher-Walker CL, Raizes EG, Mutenda N, Hunter CJ, Dean N, Steegen K, Kana V, Carmona S, Yang C, Tang AM, Parkin N, Hong SY. (2020). High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia. Medicine, 99(37)
Manrique-Saide P, Dean NE, Halloran ME, Longini IM, Collins MH, Waller LA, Gomez-Dantes H, Lenhart A, Hladish TJ, Che-Mendoza A, Kirstein OD, Romer Y, Correa-Morales F, Palacio-Vargas J, Mendez-Vales R, Pérez PG, Pavia-Ruz N, Ayora-Talavera G, Vazquez-Prokopec GM. (2020). The TIRS trial: protocol for a cluster randomized controlled trial assessing the efficacy of preventive targeted indoor residual spraying to reduce Aedes-borne viral illnesses in Merida, Mexico. Trials, 21(1)
Davis JT, Chinazzi M, Perra N, Mu K, Piontti APY, Ajelli M, Dean NE, Gioannini C, Litvinova M, Merler S, Rossi L, Sun K, Xiong X, Halloran ME, Longini IM Jr., Viboud C, Vespignani A. (2020). Estimating the establishment of local transmission and the cryptic phase of the COVID-19 pandemic in the USA. medRxiv : the preprint server for health sciences
Aleta A, Martín-Corral D, Pastore Y Piontti A, Ajelli M, Litvinova M, Chinazzi M, Dean NE, Halloran ME, Longini IM Jr., Merler S, Pentland A, Vespignani A, Moro E, Moreno Y. (2020). Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19. Nature human behaviour
Yang Yang, Lu Qingbin, Liu Mingjin, Wang Yixing, Zhang Anran, Jalali Neda, Dean Natalie, Longini Ira, Halloran M. Elizabeth, Xu Bo, Zhang Xiaoai, Wang Liping, Liu Wei, Fang Liqun. (2020). Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. Cold Spring Harbor Laboratory Press
Dean NE, Gsell PS, Brookmeyer R, Crawford FW, Donnelly CA, Ellenberg SS, Fleming TR, Halloran ME, Horby P, Jaki T, Krause PR, Longini IM, Mulangu S, Muyembe-Tamfum JJ, Nason MC, Smith PG, Wang R, Henao-Restrepo AM, De Gruttola V. (2020). Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks. The New England journal of medicine, 382(14)
Dean NE. (2019). RE: "MEASUREMENT OF VACCINE DIRECT EFFECTS UNDER THE TEST-NEGATIVE DESIGN". American journal of epidemiology, 188(4)
Ding AA, Wu SS, Dean NE, Zahigian RS. (2019). Two-stage adaptive enrichment design for testing an active factor. Journal of biopharmaceutical statistics, 30(1)
Hunt GM, Ledwaba J, Kalimashe M, Salimo A, Cibane S, Singh B, Puren A, Dean NE, Morris L, Jordan MR. Provincial and national prevalence estimates of transmitted HIV-1 drug resistance in South Africa measured using two WHO-recommended methods. Antiviral therapy, 24(3)
Dean NE, Gsell PS, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, Jasseh M, Nason M, Riveros X, Watson CH, Henao-Restrepo AM, Longini IM. (2019). Design of vaccine efficacy trials during public health emergencies. Science translational medicine, 11(499)
Dean NE, Halloran ME, Longini IM. (2018). Design of vaccine trials during outbreaks with and without a delayed vaccination comparator. The annals of applied statistics, 12(1)
Ma MJ, Zhao T, Chen SH, Xia X, Yang XX, Wang GL, Fang LQ, Ma GY, Wu MN, Qian YH, Dean NE, Yang Y, Lu B, Cao WC. (2018). Avian Influenza A Virus Infection among Workers at Live Poultry Markets, China, 2013-2016. Emerging infectious diseases, 24(7)
Sun K, Zhang Q, Pastore-Piontti A, Chinazzi M, Mistry D, Dean NE, Rojas DP, Merler S, Poletti P, Rossi L, Halloran ME, Longini IM Jr., Vespignani A. (2018). Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015-2016 ZIKV epidemic. BMC medicine, 16(1)
Zhang Q, Sun K, Chinazzi M, Pastore Y Piontti A, Dean NE, Rojas DP, Merler S, Mistry D, Poletti P, Rossi L, Bray M, Halloran ME, Longini IM Jr., Vespignani A. (2017). Spread of Zika virus in the Americas. Proceedings of the National Academy of Sciences of the United States of America, 114(22)
Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore Y Piontti A, Dean NE, Putoto G, Carraro D, Longini IM Jr., Halloran ME, Vespignani A. (2016). Containing Ebola at the Source with Ring Vaccination. PLoS neglected tropical diseases, 10(11)
Rojas DP, Dean NE, Yang Y, Kenah E, Quintero J, Tomasi S, Ramirez EL, Kelly Y, Castro C, Carrasquilla G, Halloran ME, Longini IM. (2016). The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 21(28)
Ajelli M, Merler S, Fumanelli L, Pastore Y Piontti A, Dean NE, Longini IM Jr., Halloran ME, Vespignani A. (2016). Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis. BMC medicine, 14(1)
Dean NE, Halloran ME, Yang Y, Longini IM. (2016). Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62(10)
Fang LQ, Yang Y, Jiang JF, Yao HW, Kargbo D, Li XL, Jiang BG, Kargbo B, Tong YG, Wang YW, Liu K, Kamara A, Dafae F, Kanu A, Jiang RR, Sun Y, Sun RX, Chen WJ, Ma MJ, Dean NE, Thomas H, Longini IM Jr., Halloran ME, Cao WC. (2016). Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone. Proceedings of the National Academy of Sciences of the United States of America, 113(16)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.